Anavex Life Sciences Corp (AVXL)

[falconer66a]

Waiting now for three things.

The clinical trial results are positive, with validating statistical significance metrics. Now, a matter of time and events for useful impacts.

Just how (or if) the news and broadcast press announces today's news will be interesting. How will that news affect the public's perception of Anavex in general, and blarcamesine in particular? That's the first thing I'm waiting to learn about.

The other thing is how this gets discussed by family members with PDD. My brother in law has Parkinson's; but the dementia has not yet appeared. Very good chance blarcamesine, if taken soon, can slow or stop the appearance of that disease's dementia. I've already emailed my sister about today's news. She and her husband are in contact with others suffering from PD. How will the Parkinson's disease community receive today's news? Will Parkinson's stakeholders bring new pressures on the FDA, etc.?

But the real seal-the-deal info will be what appears at a Parkinson's disease conference, or appearing in a peer-reviewed journal, when the minute details of patient responses will be presented.